2023 Canadian Urological Association guideline: Genetic testing in prostate cancer

Authors

  • Ricardo A. Rendon Dalhousie University
  • Shamini Selvarajah University of Toronto
  • Alexander W. Wyatt Department of Urologic Sciences, University of British Columbia
  • Michael Kolinsky University of Alberta
  • Kasmintan A. Schrader BC Cancer - Vancouver Centre
  • Neil E. Fleshner University of Toronto
  • Adam Kinnaird University of Alberta
  • Jennifer Merrimen Dalhousie University
  • Tamim Niazi McGill University
  • Fred Saad Université de Montréal
  • Bobby Shayegan McMaster University
  • Lori Wood Dalhousie University
  • Kim N. Chi BC Cancer - Vancouver Centre

DOI:

https://doi.org/10.5489/cuaj.8588

Keywords:

Genetic testing, prostate cancer, germline testing

Downloads

Download data is not yet available.

Published

2023-10-03

How to Cite

Rendon, R. A., Selvarajah, S. ., Wyatt, A. W., Kolinsky, M. ., Schrader, K. A. ., Fleshner, N. E. ., Kinnaird, A. ., Merrimen, J. ., Niazi, T. ., Saad, F. ., Shayegan, B. ., Wood, L. ., & Chi, K. N. (2023). 2023 Canadian Urological Association guideline: Genetic testing in prostate cancer. Canadian Urological Association Journal, 17(10), 314–25. https://doi.org/10.5489/cuaj.8588

Issue

Section

CUA Guideline

Similar Articles

You may also start an advanced similarity search for this article.